Techno Medical PCLBKK:TM-R 77 EV-to-EBITDA is 7.33 as of Jul. 07, 2026, which is 51% below its 10-year median of 15.07. GuruFocus rates BKK:TM-R with a GF Score™ of 77/100 and a GF Value™ of ฿2.99. The stock has 6 warning signs investors should review. Among 97 Medical Distribution companies, Techno Medical PCL ranks better than 58.76% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Techno Medical PCL's enterprise value is ฿610.9 Mil.
Techno Medical PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿83.4 Mil. Therefore, Techno Medical PCL's EV-to-EBITDA for today is 7.33.
The historical rank and industry rank for Techno Medical PCL's EV-to-EBITDA or its related term are showing as below:
BKK:TM-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.77 Med: 15.07 Max: 32.66
Current: 7.33
During the past 11 years, the highest EV-to-EBITDA of Techno Medical PCL was 32.66. The lowest was 6.77. And the median was 15.07.
BKK:TM-R's EV-to-EBITDA is ranked better than 58.76% of 97
companies
in the Medical Distribution industry
Industry Median: 8.94
vs BKK:TM-R: 7.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Techno Medical PCL (BKK:TM-R) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Techno Medical PCL's PE Ratio (TTM) for today is calculated as:
Techno Medical PCL's share price for today is ฿2.32.
Techno Medical PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.093.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Techno Medical PCL's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TM-R vs MCK, CAH, COR: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Techno Medical PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's EV-to-EBITDA falls into.
Techno Medical PCL's current Enterprise Value is ฿610.9 Mil.
Techno Medical PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿83.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medical PCL (BKK:TM-R) has a EV-to-EBITDA of 7.33 as of Jul. 07, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Techno Medical PCL. This is 51% below median its historical median of 15.07. Over the past decade, Techno Medical PCL's EV-to-EBITDA has ranged from 6.77 to 32.66. According to the industry distribution chart, Techno Medical PCL ranks #40 out of 97 companies in the Medical Distribution industry, placing it in the top 41.2%.
Is Techno Medical PCL's EV-to-EBITDA too high?
Techno Medical PCL's current EV-to-EBITDA of 7.33 is 51% below median its 10-year median of 15.07. Over the past 10 years, this metric has ranged from a low of 6.77 to a high of 32.66. The Medical Distribution industry median EV-to-EBITDA is 8.94. Techno Medical PCL's value of 7.33 is 18% below this industry median. Based on the distribution chart, Techno Medical PCL ranks #40 out of 97 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Techno Medical PCL has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's EV-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #40 out of 97 companies for EV-to-EBITDA. This puts Techno Medical PCL in the upper half of its industry. The industry median EV-to-EBITDA is 8.94. Techno Medical PCL's value of 7.33 is 18% below this benchmark. Historically, Techno Medical PCL's own EV-to-EBITDA has ranged from 6.77 to 32.66 over the past decade. While the company's 10-year median is 15.07 vs. the industry median of 8.94, Techno Medical PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.94, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current EV-to-EBITDA of 7.33 is 18% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Techno Medical PCL. For the Medical Distribution industry, the median EV-to-EBITDA is 8.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current EV-to-EBITDA is 7.33, which is 51% below median its own 10-year median of 15.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current EV-to-EBITDA of 7.33. The stock's GF Value™ is ฿2.99, compared to a current price of ฿2.32 — trading 22.4% below its estimated fair value. The current EV-to-EBITDA is 7.33, which is 51% below median its 10-year median of 15.07 and 18% below the Medical Distribution industry median of 8.94. Techno Medical PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current EV-to-EBITDA is 7.33 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 22.4% below its estimated GF Value™ of ฿2.99.
Key valuation signals for BKK:TM-R:
EV-to-EBITDA: 7.33 (51% below median its 10-year median of 15.07)
GF Value™: ฿2.99 vs. price of ฿2.32 (22.4% below fair value)
Industry Position: 18% below the Medical Distribution median (#40 of 97)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
77GF Score
Get the complete analysis for BKK:TM-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 
